Axonics Total Liabilities 2017-2023 | AXNX
Axonics total liabilities from 2017 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
| Axonics Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $82 |
| 2022 | $89 |
| 2021 | $66 |
| 2020 | $55 |
| 2019 | $37 |
| 2018 | $29 |
| 2017 | $3 |
| 2016 | $2 |
| Axonics Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2023-12-31 | $82 |
| 2023-09-30 | $50 |
| 2023-06-30 | $48 |
| 2023-03-31 | $89 |
| 2022-12-31 | $89 |
| 2022-09-30 | $83 |
| 2022-06-30 | $76 |
| 2022-03-31 | $62 |
| 2021-12-31 | $66 |
| 2021-09-30 | $71 |
| 2021-06-30 | $61 |
| 2021-03-31 | $115 |
| 2020-12-31 | $55 |
| 2020-09-30 | $54 |
| 2020-06-30 | $51 |
| 2020-03-31 | $45 |
| 2019-12-31 | $37 |
| 2019-09-30 | $34 |
| 2019-06-30 | $32 |
| 2019-03-31 | $28 |
| 2018-12-31 | $29 |
| 2018-09-30 | $18 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | |
| 2017-09-30 | $0 |
| 2016-12-31 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.435B | $0.366B |
| Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction and disrupting the SNM market. Axonics Modulation Technologies Inc. is based in Irvine, CA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.987B | 20.31 |
| Inspire Medical Systems (INSP) | United States | $4.742B | 0.00 |
| 10x Genomics (TXG) | United States | $3.214B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.075B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.923B | 0.00 |
| Enovis (ENOV) | United States | $2.836B | 21.02 |
| Hims & Hers Health (HIMS) | United States | $2.769B | 0.00 |
| Azenta (AZTA) | United States | $2.768B | 155.58 |
| Privia Health (PRVA) | United States | $2.147B | 119.93 |
| Schrodinger (SDGR) | United States | $1.685B | 0.00 |
| Omnicell (OMCL) | United States | $1.414B | 48.89 |
| Phreesia (PHR) | United States | $1.241B | 0.00 |
| Standard BioTools (LAB) | United States | $0.719B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.664B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.640B | 0.00 |
| Talkspace (TALK) | United States | $0.484B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.452B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.401B | 0.00 |
| Pulmonx (LUNG) | United States | $0.340B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.299B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.201B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.199B | 0.00 |
| Outset Medical (OM) | United States | $0.160B | 0.00 |
| American Well (AMWL) | United States | $0.145B | 0.00 |
| TruBridge (TBRG) | United States | $0.133B | 7.15 |
| Augmedix (AUGX) | United States | $0.115B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.113B | 0.00 |
| 111 (YI) | China | $0.108B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.077B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.058B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| Movano (MOVE) | United States | $0.041B | 0.00 |
| CareCloud (CCLD) | United States | $0.037B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Cue Health (HLTH) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |